SM
IDNA icon

Sweeney & Michel’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Sweeney & Michel’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,570
Closed -$411K – 106
2023
Q2 		$411K Sell
18,570
-5,212
-22% -$125K 0.21% 75
2023
Q1 		$589K Buy
+23,782
New +$595K 0.31% 52

Other funds holding IDNA

WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Sweeney & Michel's IDNA Position: Q3 2023 in Review

Sweeney & Michel sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2023, closing a stake of 18,570 shares — an estimated $411K sold.

Sweeney & Michel first reported a position in IDNA in Q1 2023 and held it in 2 quarters. The position peaked at $589K in Q1 2023. 66 funds tracked by Wall St. Rank hold IDNA as of Q3 2023.

  • Sweeney & Michel reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2023 after selling out during the quarter.
  • Sweeney & Michel sold 18,570 iShares Genomics Immunology and Healthcare ETF shares in Q3 2023, an estimated $411K.
  • Sweeney & Michel first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2023 and held it in 2 quarters.
  • Sweeney & Michel's iShares Genomics Immunology and Healthcare ETF position peaked at $589K in Q1 2023.
  • 66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2023.

Based on Sweeney & Michel's 13F filing for Q3 2023, filed 9 Nov 2023.